Avalo Therapeutics (AVTX) Operating Margin Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.25 Mn |
| Dec 31, 2024 | 126,947.00 |
| Sep 30, 2024 | -394,558.00 |
| Dec 31, 2023 | -24,971.00 |
| Sep 30, 2023 | -39,393.00 |
| Jun 30, 2023 | -22,894.00 |
| Mar 31, 2023 | -71,032.00 |
| Dec 31, 2022 | -296.00 |
| Sep 30, 2022 | 15,739.00 |
| Jun 30, 2022 | -96,196.00 |
| Mar 31, 2022 | -158,349.00 |
| Dec 31, 2021 | -822,696.00 |
| Sep 30, 2021 | -62,280.00 |
| Jun 30, 2021 | -39,033.00 |
| Mar 31, 2021 | -638,137.00 |
| Dec 31, 2020 | -86,345.00 |
| Sep 30, 2020 | -128,260.00 |
| Jun 30, 2020 | 24,180.00 |
| Mar 31, 2020 | -64,633.00 |
| Dec 31, 2019 | -5,876.00 |
| Sep 30, 2019 | 172,485.00 |
| Jun 30, 2019 | 35,316.00 |